Future Perspective of Pharmacoepidemiology

Abstract

Pharmacoepidemiology seems to be playing an increasingly important part in industry and will probably continue to do so. Everything that was said above regarding the scientific future of pharmacoepidemiology and how it relates to academia also clearly applies to industry. Many people in the business have realized the importance of pharmacoepidemiology. Manufacturers are starting to understand that the field can help with more than just understanding how their drugs work; it can also help with recording drug safety and creating and assessing risk management programs. Pharmacoepidemiology seems to be playing a bigger part in regulating organizations. In addition, this book details numerous significant drug disasters that have occurred. Many of these events had the effect of taking the drugs off the market. Pharmacoepidemiology investigations are essential and essential, and this has become obvious. Once more, we can anticipate that this will persist in the future. Every drug has side effects. Pharmacoepidemiology will never be able to successfully stop them. It can only identify them, ideally early, and inform the public and healthcare professionals as a result, improving drug utilisation. The public's health will benefit most from expanded pharmacoepidemiology activity, but industry and academia will also benefit. In addition, it can enhance the use of medicines that serve a real purpose while preventing the loss of effective medications. Hopefully, the usefulness will be highlighted and the issues will be resolved over the coming years.